########################################
# Program: needle
# Rundate: Wed 30 May 2018 16:57:54
# Commandline: needle
#    -outfile /Users/teresatavella/Documents/models_new/seqid30_low85/gb_CCP44620.1_ARO_3003461_Mycobacterium_4nwz_D/needle.txt
#    -asequence /Users/teresatavella/Documents/models_new/seqid30_low85/gb_CCP44620.1_ARO_3003461_Mycobacterium_4nwz_D/gb_CCP44620.1_ARO_3003461_Mycobacterium_tuberculosis_ndh_mutant_conferring_resistance_to_isoniazid__Mycobacterium_tuberculosis_H37Rv.fa
#    -bsequence /Users/teresatavella/Documents/models_new/seqid30_low85/gb_CCP44620.1_ARO_3003461_Mycobacterium_4nwz_D/4nwz_D.fa
#    -gapopen 10
#    -gapextend 0.5
# Align_format: srspair
# Report_file: /Users/teresatavella/Documents/models_new/seqid30_low85/gb_CCP44620.1_ARO_3003461_Mycobacterium_4nwz_D/needle.txt
########################################

#=======================================
#
# Aligned_sequences: 2
# 1: gb_CCP44620.1_ARO_3003461_Mycobacterium_tuberculosis_ndh_mutant_conferring_resistance_to_isoniazid__Mycobacterium_tuberculosis_H37Rv
# 2: 4nwz_D_mol_protein_length_405__FAD-dependent_pyridine_nucleotide-disulfide_oxidoreductase
# Matrix: EBLOSUM62
# Gap_penalty: 10.0
# Extend_penalty: 0.5
#
# Length: 479
# Identity:     120/479 (25.1%)
# Similarity:   194/479 (40.5%)
# Gaps:         122/479 (25.5%)
# Score: 367.0
# 
#
#=======================================

gb_CCP44620.1      1 MSPQQEPTAQPPRRHRVVIIGSGFGGLNAA----KKLKRADVDIKLIART     46
                                   ..:||:|:|:||:.||    |:|...:.||.|:.:.
4nwz_D_mol_pr      1 --------------PSIVILGAGYGGIVAALGLQKRLNYNEADITLVNKN     36

gb_CCP44620.1     47 THHLFQPLLYQVATGIISEGEIAPPTRVVLRKQRNVQVLLGNVTHIDLAG     96
                     .:|.....|:|.|.|.:...:    .||.:::       |.:...|....
4nwz_D_mol_pr     37 DYHYITTELHQPAAGTMHHDQ----ARVGIKE-------LIDEKKIKFVK     75

gb_CCP44620.1     97 QCVVSELLGHTYQTPYDSLIVAAGAGQSYFGNDHFAEFAPGMKSIDDALE    146
                     ..||:.|  ...:..||.|:|..|:....||.:...|.|..:.||:....
4nwz_D_mol_pr     76 DTVVATL--QNGELHYDYLVVGLGSEPETFGIEGLREHAFSINSINSVRI    123

gb_CCP44620.1    147 LRGRILSAFEQAERSSDPERRAKLLTFTVVGAGPTGVEMAGQIAE-----    191
                     :|..|  .::.|:.:::|| |...||..|.|||.||:|..|::|:     
4nwz_D_mol_pr    124 IRQHI--EYQFAKFAAEPE-RTDYLTIVVGGAGFTGIEFVGELADRMPEL    170

gb_CCP44620.1    192 LAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLGV    241
                     .||:       .:|....|:|.::|||.|||.....|...|...|...||
4nwz_D_mol_pr    171 CAEY-------DVDPKLVRIINVEAAPTVLPGFDPALVNYAMDVLGGKGV    213

gb_CCP44620.1    242 EIQLGAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAE    291
                     |.::|..:......|:.: :.||....|::|..||:.||.    |..:.|
4nwz_D_mol_pr    214 EFKIGTPIKRCTPEGVVI-EVDGEEEEIKAATVVWTGGVR----GNSIVE    258

gb_CCP44620.1    292 QSRVELDRAGRVQVLPDLSIPGYPNVFVVGDMAAV------EGVPGVAQG    335
                     :|..|..| ||::|.|.|..||:.|:|:|||.|.:      ...|..||.
4nwz_D_mol_pr    259 KSGFETMR-GRIKVDPYLRAPGHENIFIVGDCALIINEENNRPYPPTAQI    307

gb_CCP44620.1    336 AIQGAKYVASTIKAELAGANPAEREPFQYFDKGSMATVSRFSAVAKIGPV    385
                     |||..:.||:.:.|.:.        ||:...:|::|::.|..|:.     
4nwz_D_mol_pr    308 AIQHGENVAANLAALMT--------PFKPHIRGTVASLGRNDAIV-----    344

gb_CCP44620.1    386 EFSGFIAWLIWLV-LHLAYLIGFKTKITTLLSWTVTFLSTRRGQLTITDQ    434
                      :....:||..|: :...||||..:.:...                    
4nwz_D_mol_pr    345 -YGHAASWLKKLIDMRYLYLIGGLSLVLKK--------------------    373

gb_CCP44620.1    435 QAFARTRLEQLAELAAEAQGSAASAKVAS    463
                                                  
4nwz_D_mol_pr    373 -----------------------------    373


#---------------------------------------
#---------------------------------------